Steven Boyd Overview

  • Primary Position
  • Founder, Chief...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

Steven Boyd General Information

Biography

Mr. Steven Boyd is the Founder and serves as Chief Investment Officer and Managing Partner at Armistice Capital. He serves as the Chief Investment Officer at Armistice Capital, and as Board Member at Aytu Biopharma. He served as Board Member at Kiora Pharmaceuticals. He has served on Cerecor's Board of Directors since May 2017. He was a Senior Research Analyst at Senator Investment Group (from February 2008 to January 2012). Prior to joining Senator, he was an Associate at York Capital, focusing primarily on investments in consumer and healthcare equities, from February 2007 to January 2008. Prior to York, he was an Analyst at SAB Capital Management, a value-oriented long/short equity hedge fund. He began his career as an Analyst at McKinsey & Company. He received a B.S. in Economics (with a concentration in Finance) as well as a B.A. in Political Science from The Wharton School of the University of Pennsylvania.

Contact Information

Primary Position
Founder, Chief Investment Officer & Managing Partner, Armistice Capital
Education
University of Pennsylvania (Wharton), BS (Bachelor of Science)
University of Pennsylvania (Wharton), BA (Bachelor of Arts)
Gender
Male
Email
sb
Phone
+1 (212)
Address
  • 510 Madison Avenue
  • New York, NY 10022
  • United States
+1 (212)

Steven Boyd Positions (1)

Firm name Firm type Title Location Industry Since
Armistice Capital Investor Founder, Chief Investment Officer & Managing Partner New York, NY Hedge Fund

Steven Boyd Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Avalo Therapeutics Biotechnology Publicly Held Formerly VC-backed Rockville, MD
Aytu Biopharma Biotechnology Publicly Held Private Debt Financed Denver, CO
Tenax Therapeutics Pharmaceuticals Publicly Held Formerly Angel backed Chapel Hill, NC

Steven Boyd Lead Partner on Deals (2)

Steven Boyd has been the lead partner on 2 deals. Their latest deal was with Kiora Pharmaceuticals, a drug discovery company. The deal was made for on 05-Jan-2021.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Kiora Pharmaceuticals 05-Jan-2021 PIPE Completed Drug Discovery Encinitas, CA
Avalo Therapeutics 28-Apr-2017 Completed Biotechnology Rockville, MD

Steven Boyd Network (96)

Board Members (61)

Name Company Representing Location From
Peter Greenleaf Kiora Pharmaceuticals Self Encinitas, CA
Peter Greenleaf Avalo Therapeutics Self Rockville, MD
Aytu Biopharma Self Denver, CO
Tenax Therapeutics Self Chapel Hill, NC
Avalo Therapeutics New Enterprise Associates Rockville, MD

Portfolio Executives (35)

Name Company Role Deal date Location
Stefan Sperl Ph.D Kiora Pharmaceuticals Executive Vice President CMC and Operations 05-Jan-2021 Encinitas, CA
Susan Drexler Kiora Pharmaceuticals Chief Financial Officer, Finance & Chief Accounting Officer, Accounting 05-Jan-2021 Encinitas, CA
Kiora Pharmaceuticals President, Chief Executive Officer & Board Member 05-Jan-2021 Encinitas, CA
Kiora Pharmaceuticals Executive 05-Jan-2021 Encinitas, CA
Kiora Pharmaceuticals Chief Financial Officer, Finance & Chief Accounting Officer, Accounting 05-Jan-2021 Encinitas, CA

Steven Boyd FAQs

  • Who is Steven Boyd?

    Mr. Steven Boyd is the Founder and serves as Chief Investment Officer and Managing Partner at Armistice Capital.

  • How much does Steven Boyd typically invest?

    Steven Boyd's median deal size is .

  • What is Steven Boyd’s main position?

    Steven Boyd’s primary position is Founder, Chief Investment Officer & Managing Partner.

  • What are the contact details for Steven Boyd?

    Steven Boyd’s email address is sb and his phone number is +1 (212) .

  • How many active board seats does Steven Boyd hold?

    Steven Boyd holds 3 board seats including Avalo Therapeutics, Aytu Biopharma, and Tenax Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »